Numerous studies have shown the link between brain-derived neurotrophic factor/tropomyosin kinase receptor B (BDNF/TrkB) pathway activation and the improvement of neurological disorders, such as AD or major depressive disorder [5,6,7,8]. Here, NTRK2 is linked to nervous system disorder.